Financials

  • Market Capitalization 4.1 B
  • Employee 137
  • Founded 2017
  • CEO N/A
  • Website www.tangotx.com
  • Headquarter Delaware, United States
  • FIGI BBG00WFDDRS0
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-10.18
Relación precio/flujo de caja
16.5

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1436
ACAD
ACADIA Pharmaceuticals Inc. - Common Stock
25.50 USD-2.75%-2.52%+20.85%+16.23%4.37 B USD
1463
DNLI
Denali Therapeutics Inc. - Common Stock
26.48 USD+3.12%+2.12%+21.13%+63.76%4.20 B USD
1527
NAMS
NewAmsterdam Pharma Company N.V. - Ordinary Shares
33.28 USD-5.62%-5.00%+6.74%-8.24%3.89 B USD
1535
CPRX
Catalyst Pharmaceuticals, Inc. - Common Stock
31.48 USD+0.03%-0.03%+0.38%+48.42%3.85 B USD

Noticias